ArticleMolecular and clinical oncology2019

Interval between hepatocellular carcinoma treatment and interferon-free direct-acting antiviral agents against hepatitis C is necessary to suppress tumor recurrence.

Hiroya Iida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.